Social Post
September 2026
Childhood Cancer Awareness Month
September is Childhood Cancer Awareness Month 💛
At @allterumtherapeutics, we stand with children, families, caregivers, advocates, researchers, and healthcare professionals in the fight against childhood cancer.
Every child deserves access to innovative therapies, hope for a healthier future, and the opportunity to thrive. This month, we honor the courage and resilience of young patients and their families while recognizing the dedication of the clinical investigators, nurses, and scientists working tirelessly to advance new treatment options.
Through our commitment to developing novel therapies for pediatric cancers, we remain focused on transforming scientific discoveries into meaningful outcomes for patients with unmet medical needs. Together, we continue working toward a future where every child diagnosed with cancer has more effective treatment options and brighter possibilities ahead.
💛 Childhood Cancer Awareness Month
🎗️ Supporting patients. Advancing science. Inspiring hope.
#ChildhoodCancerAwarenessMonth
#ALL
#PediatricCancer
#ChildhoodCancer
#AllterumTherapeutics
Social Post
September 2026
Patients Can't Wait
🎗️ September is Childhood Cancer Awareness Month.
Behind every diagnosis is a child, a family, and a future worth fighting for.
At Allterum Therapeutics, we are committed to advancing innovative therapies for children and adults living with difficult-to-treat blood cancers. Because for patients facing relapsed or refractory disease, patients can’t wait.
This month, we honor the children and families navigating cancer, recognize the healthcare professionals and researchers working tirelessly for better options, and continue pushing toward a future where every child has hope.
💛 For the fighters. For the families. For the future.
#ChildhoodCancerAwarenessMonth
#CCAM
#PediatricCancer
#ChildhoodCancer
#Leukemia
#ALL
#AcuteLymphoblasticLeukemia
#RareDisease
#PatientsCantWait
#AllterumTherapeutics
Video
September 2026
Clinical Trial Update: ALT-101
September is Childhood Cancer Awareness Month, we’re highlighting the people and progress behind the fight against childhood cancer. 💛🎗️
At @allterumtherapeutics, that means continuing to advance ALT-101, an investigational therapy for acute lymphoblastic leukemia (ALL), through our Phase 1 clinical trial, which is actively enrolling patients.
Hear from Justine Delgado, our Sr. Clinical Trial Manager, as she shares an update on ALT-101 and the work happening behind the study.
For the children and families waiting for new treatment options, every step forward matters.
#PatientsCantWait
